Read the latest news about scientific breakthroughs, clinical findings and special events benefiting neurofibromatosis research.
Nurturing Health and Happiness: A Physical Therapist’s Guide to Maintaining Routines and Schedules During the Winter Months
It’s the most wonderful time of the year – right? Or does it feel like the most chaotic couple of months out of your year? As the holiday season approaches, it’s easy for routines to take a backseat to festivities. While it’s important to celebrate and enjoy this special time of year, maintaining a structured […]
Dr. Corina Anastasaki, PhD Wins the Women in Neuroscience Award
On behalf of the Society of Neuro-Oncology and the SNO Women and Diversity Committee, it is my pleasure to inform you that your abstract, CNSC-43 “Targeting neuronal excitability for Nf1low-grade glioma therapy,” has been selected for the 2023 Women in Neuro-Oncology (WiN) Abstract Award in Basic/Translational Science Research at the upcoming 28th Annual Meeting of […]
NF Center Researchers Demonstrate that a Mutation in the Cytokine Receptor-Like Factor-3 (CRLF3) Gene Causes Neuronal Deficits
Children with Neurofibromatosis type 1 (NF1) are prone to intellectual and developmental disabilities, including learning and memory problems, attention deficit, autism, and developmental delays. Prior work from the laboratory of Dr. David Gutmann, Washington University NF Center Director, showed that mini-brains from children with NF1 total gene deletions have impaired nerve cell (neuron) development, particularly […]
Dr. David Gutmann Inducted Into the National Academy of Medicine
Membership in the National Academy of Medicine is considered one of the highest honors in the fields of health and medicine and recognizes individuals who have demonstrated outstanding professional achievement and commitment to service. About Dr. Gutmann, MD, PhD Dr. David H. Gutmann, the Donald O. Schnuck Family Professor in Neurology, was elected in 2022 […]
Josh Breunig, David Gutmann, and Yuan Pan receive a Collaborative Department of Defense Grant
The Department of Defense Neurofibromatosis (NF) Research Program recently awarded Drs. Joshua Breunig (Cedars Sinai), David Gutmann (Washington University), and Yuan Pan (MD Anderson Cancer Center) a three-year grant to study NF1-associated brain tumors. The team will leverage a state-of-the-art genetic technology called Mosaic Analysis with Dual Recombinases (MDAR) to model brain tumors in NF1 […]